Navigation Links
QualityMetric Announces QM Certified Scoring Program
Date:7/15/2008

Company unveils landmark program to help clients avoid costly and

potentially embarrassing mistakes when collecting outcomes data

LINCOLN, R.I., July 15 /PRNewswire/ -- It seems that every month there is a news story questioning the integrity of outcomes data in clinical trials. Just recently, the Ketek(R) controversy has been in the news. The truth is, no matter who is collecting the data or what it is being used for, mistakes are easy to make and difficult to recognize until it is too late.

To address this problem, QualityMetric Incorporated has developed QM Certified Scoring(TM). The program is designed for researchers, clinicians, clinical trial administrators, and other healthcare administrators who insist on high quality and are committed to properly collecting, scoring, and interpreting their health outcomes data.

Over the years, data quality issues have haunted several large-scale outcomes studies in the academic and clinical trial worlds. Several organizations have scored data from the SF-36v2(R) Health Survey using homemade computer programs with scoring algorithms and norms provided by QualityMetric publications. Minor mistakes in the programming code or simple formatting errors have lead to incorrect scores and misinterpreted results, in some cases leading to millions of dollars in lost revenue.

"Unfortunately, the do-it-yourself approach can, and has, resulted in significant data quality problems." says Mark Kosinski, MA, Senior Scientist and Director of QualityMetric's Outcomes Insight Consulting(TM) Group. "There are alarming examples of what can go wrong and the results can be very costly.

Using any of our QM Certified Scoring products will give outcomes professionals peace of mind when it comes to the data they will be using to make important decisions about medical products, the effectiveness of medical interventions, or population health monitoring efforts. QM Certified Scoring is available via the web, at the desktop, or as an enterprise-wide solution residing on client servers. There is also a version that includes further analysis and insight from a member of our Outcomes Insight Consulting Team. Visit http://www.qualitymetric.com/download/QMCertifiedScoring.zip for more product details.

About QualityMetric - QualityMetric Incorporated works with the world's largest healthcare and life sciences companies to measure health outcomes. Our products help market new drugs and biologics, track health improvement or decline, screen populations for disease, and identify future health risks. QualityMetric's patient-reported outcome (PRO) surveys provide scientifically valid assessments of both physical and mental health. Our PROs include the SF-36v2(R), SF-12v2(R), and SF-8(TM) Health Surveys, SF-10(TM) Health Survey for Children, Asthma Control Test (ACT(TM)), Pain Impact Questionnaire (PIQ-6(TM)), and DYNHA(R) Dynamic Health Assessments. Our Outcomes Insight Consulting(TM) Group can develop customized PROs and provide in-depth analysis of the results. QualityMetric's founder and CEO, John E. Ware, Jr., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at http://www.qualitymetric.com


'/>"/>
SOURCE QualityMetric Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Capitol Hill neighborhood, with its swanky shops, parks and cafés, might ... salon to set up shop. But there,s Hair Fairies ... on E Madison Ave, and CEO Maria Botham ... we pride ourselves on being a destination for parents and ... associated with lice. Everyone can get lice – it doesn,t ...
(Date:2/23/2017)... ... February 23, 2017 , ... David ... Inventors Recognition Reception at Purdue Research Park of West Lafayette, Indiana. ... recognition of outstanding contributions to, and success with, commercializing discoveries from Purdue research. ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
(Date:2/22/2017)... LOS ANGELES, CA (PRWEB) , ... February 22, ... ... company, today announced that is has acquired Kendall Research Systems, LLC ... of Technology (MIT) that develops neural interface technology for research and clinical applications. ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
Breaking Biology News(10 mins):